Tradestie Institutional Equity Comparison Engine

MDT vs AXNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MDT Overall Edge

MDT Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medtronic plc (MDT) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, MDT trades at 16.5x Forward P/E with 20.1% operating margin (+13.7% YoY revenue) versus AXNX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MDT sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MDT
MDT 16.5x vs AXNX N/M Fwd P/E
Growth & Margin Winner MDT
Op Margin 20.1% vs N/A ยท YoY +13.7% vs N/A
Momentum & Technical Winner AXNX
1Y -0.4% vs +16.9% ยท 52W Pos 81% vs 50%
Options & Structure Winner MDT
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (N/A IV)
MDT NYSE
Medtronic plc
Electromedical & Electrotherapeutic Apparatus
$99.94
-0.67% 1D
Market Cap $128.7B
1M Return +3.47%
1Y Return -0.4%
Forward P/E 16.5x
Unified AI Score
44.7 / 100 HOLD
Tech 31.0 Fund 49.0 Flow 72.0 Mom 46.0
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MDT -0.4% AXNX +16.92% Spread: +9.47 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MDT TTM Op. Margin: 20.1% AXNX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MDT vs AXNX. Trailing 12-month operating profitability (MDT 20.1% vs AXNX N/A) and valuation multiples (MDT 16.5x vs AXNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MDT (9) vs AXNX (1)
Institutional Metric MDT AXNX Criterion Row Winner
Market Capitalization Scale $128.7B N/A Larger Scale MDT
Trailing P/E Ratio Valuation 24.7x N/M Lower Multiple MDT
Forward P/E Ratio Valuation 16.5x N/M Lower Multiple MDT
Revenue Growth (YoY) Growth +13.7% N/A Higher Growth MDT
Operating Margin (TTM) Profitability 20.1% N/A Higher Margin MDT
Net Profit Margin Profitability 13.9% N/A Higher Margin MDT
Return on Equity (ROE) Capital Efficiency 10.7% N/A Higher ROE MDT
52-Week Range Position Momentum 81% ($73โ€“$106) 50% ($0โ€“$1) Stronger Trend MDT
Beta / 30D Volatility Risk Regime 0.13ฮฒ ยท 30% Vol N/A Lower Realized Risk MDT
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 52.1 / 100 (HOLD) Higher Composite AXNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MDT vs AXNX Buy Guide
MDT CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live MDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MDT nor AXNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.